MEDIFAST INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $17.8m $27.7m $55.8m $77.9m $102.9m $164.0m $143.6m $99.4m $2.1m ($18.7m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $17.8m $27.7m $55.8m
Depreciation, Depletion and Amortization $5.4m $4.2m $4.4m $4.6m $7.3m $6.8m $11.0m $13.1m $12.7m $14.2m
Capitalized Computer Software, Amortization $200k
Depreciation $5.4m $4.2m $4.4m $4.6m $7.3m $6.8m $7.9m $10.0m $17.4m $10.5m
Deferred Income Tax Expense (Benefit) ($2.8m) ($623k) ($2.7m) $1.6m $601k ($3.7m) ($924k) $1.2m ($7.4m) $11.5m
Share-based Payment Arrangement, Noncash Expense $3.4m $4.3m $3.1m $4.5m $6.8m $9.9m $11.1m $8.2m $7.4m $7.6m
Share-based Payment Arrangement, Expense $9.9m $11.1m $8.2m $7.4m $7.6m
Restructuring Costs and Asset Impairment Charges $12.5m $12.5m
Gain (Loss) on Disposition of Property Plant Equipment ($12k) ($94k) ($48k) ($17k) ($212k) ($2k) ($2.1m) ($1.2m) ($89k) ($1.4m)
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $12k $94k $3k $17k $212k $2k $2.1m $1.2m $89k $1.4m
Income Tax Expense (Benefit) $9.3m $12.6m $14.8m $14.4m $31.4m $52.1m $40.5m $29.4m $1.7m $13.0m
Operating Lease, Expense $3.6m $5.6m $6.7m $5.1m $4.9m $4.9m
Other Nonoperating Income (Expense) ($20k) $136k $179k $29k ($140k) $119k ($46k) ($95k) $3.1m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($246k) ($815k) ($122k) $4.1m ($297k)
Increase (Decrease) in Inventories $5.0m $1.0m $18.7m $9.9m $4.6m $126.7m ($61.2m) ($64.3m) ($12.2m) ($22.2m)
Accounts Receivable, Credit Loss Expense (Reversal) $3.6m $556k
Proceeds from Stock Options Exercised $299k $568k $547k $278k $1.6m $800k $188k $36k $0
Debt and Equity Securities, Realized Gain (Loss) $0 $0 $0 $0 ($150k) $4.1m ($17k)
Debt Securities, Realized Gain (Loss) $0 $0 $95k $3.3m
Equipment Expense $700k $200k $100k
Equity Securities, FV-NI, Gain (Loss) $0 $150k ($4.1m) ($17k)
Equity Securities, FV-NI, Realized Gain (Loss) $0 $0 $0 ($17k)
Equity Securities, FV-NI, Unrealized Gain (Loss) $0 $150k ($4.1m) $17k
Marketable Securities, Unrealized Gain (Loss) $36k $87k $21k $0 ($150k) $4.1m ($17k)
Nonoperating Income (Expense) $263k $694k $1.5m $1.3m $106k ($112k) ($747k) $2.4m $909k $8.6m
Restructuring Costs $12.2m
Revenue from Contract with Customer, Including Assessed Tax $1.5b $1.6b
Unrealized Gain (Loss) on Investments $0 $150k ($17k)
Net Cash Provided by (Used in) Operating Activities $25.4m $43.2m $60.8m $84.3m $145.2m $94.5m $194.6m $147.7m $24.5m $6.9m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $2.9m $3.2m $4.9m $10.1m $5.9m $34.2m $16.7m $6.5m $7.5m $5.6m
Payments to Acquire Investments $26.6m $7.0m
Gain (Loss) on Sale of Investments ($313k) ($82k) ($3k)
Net Cash Provided by (Used in) Investing Activities ($2.0m) ($3.2m) ($1.2m) ($6.3m) ($1.3m) ($29.1m) ($11.4m) ($61.0m) ($26.5m) ($7.9m)
Cash flows from financing activities:
Repayments of Long-term Debt $219k
Payments for Repurchase of Common Stock $30.0m $33.1m $5.0m $56.0m $126.4m $3.6m $0 $0
Dividends paid $11.9m $15.4m $23.2m $35.4m $53.2m $63.9m $71.6m $73.0m $715k $195k
Payments of Dividends $11.9m $15.4m $23.2m $35.4m $53.2m $63.9m $71.6m $73.0m $715k $195k
Dividends Payable, Current $4.0m $6.1m $9.1m $13.7m $13.8m $17.2m $19.6m $1.4m $648k $295k
Net Cash Provided by (Used in) Financing Activities ($12.9m) ($17.4m) ($53.3m) ($82.3m) ($57.1m) ($125.1m) ($199.6m) ($79.8m) ($1.5m) ($564k)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $112k ($67k) ($72k) $47k $4k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $10.4m $22.6m $6.3m ($4.4m) $86.7m ($59.5m) ($16.5m) $6.7m ($3.5m) ($1.6m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $77.0m $163.7m $104.2m $87.7m $94.4m $90.9m $89.3m
Cash, Cash Equivalents, and Short-term Investments $87.7m $149.2m $165.6m $166.4m
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net $11.6m $13.6m $14.6m $17.3m $24.6m $56.8m $37.2m $34.3m ($1.6m) $10.5m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.